Evidence map›Paper›PMID 28093464›Full record

ArticlePediatrics2017

Socioeconomic Status, Smoke Exposure, and Health Outcomes in Young Children With Cystic Fibrosis.

Thida Ong, Michael Schechter, Jing Yang, Limin Peng, Julia Emerson, Ronald L Gibson, Wayne Morgan, Margaret Rosenfeld, EPIC Study Group

Open access · bronzeAbstract read
In one paragraph

Article in Pediatrics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 31 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
31citing papers in PubMed, 1 pooled it
6.7field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

31 citing papers in PubMed, 1 synthesis or guideline pooled it, 70 citations in OpenAlex.

  1. Pooled it
  2. Association between biomarkers of tobacco smoke exposure and clinical efficacy of ivacaftor in the G551D observational trial (GOAL).Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2024
    Observational
  3. Multigenerational inequalities of opportunity in health outcomes.International journal for equity in health · 2024
    Article
  4. Review
  5. Review
  6. Article
  7. Quality of anthropometric data measured in children and adolescents with cystic fibrosis: a scoping review.Revista paulista de pediatria : orgao oficial da Sociedade de Pediatria de Sao Paulo · 2023
    Article
  8. Association between early respiratory viral infections and structural lung disease in infants with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Article
  9. Review
  10. Review
  11. Association between insurance variability and early lung function in children with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2022
    Observational
  12. Telehealth use in cystic fibrosis during COVID-19: Association with race, ethnicity, and socioeconomic factors.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  13. Article
  14. Tobacco smoke exposure limits the therapeutic benefit of tezacaftor/ivacaftor in pediatric patients with cystic fibrosis.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  15. Cessation of smoke exposure improves pediatric CF outcomes: Longitudinal analysis of CF Foundation Patient Registry data.Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  16. Speaking of pandemics...Journal of cystic fibrosis : official journal of the European Cystic Fibrosis Society · 2021
    Article
  17. Review
  18. The Impact of Environmental Factors on Monogenic Mendelian Diseases.Toxicological sciences : an official journal of the Society of Toxicology · 2021
    Article
  19. Social Inequities and Cystic Fibrosis Outcomes: We Can Do Better.Annals of the American Thoracic Society · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 4 institutions in 1 country.

Thida OngDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington; thida.ong@seattlechildrens.org.
Michael SchechterDivision of Pulmonary Medicine, Department of Pediatrics, Virginia Commonwealth University, Children's Hospital of Richmond at VCU, Richmond, Virginia.
Jing YangDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia; and.
Limin PengDepartment of Biostatistics and Bioinformatics, Emory University, Atlanta, Georgia; and.
Julia EmersonDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.
Ronald L GibsonDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.
Wayne MorganDepartments of Pediatrics and Physiology, Pediatric Pulmonary Center, University of Arizona, Tucson, Arizona.
Margaret RosenfeldDivision of Pulmonary and Sleep Medicine, Department of Pediatrics, University of Washington, Seattle, Washington.
EPIC Study Group
University of Washington · USEmory University · USUniversity of Arizona · USVirginia Commonwealth University · US

Funding

Translational Research Center to Expedite Novel Therapies in Cystic FibrosisP30DK089507 · NIDDK · SEATTLE CHILDREN'S HOSPITAL · PI Christopher Hooper Goss, Lucas R Hoffman · 2010 to 2026
$21.4M
Method Development for Survival Dynamic Regression in Chronic Disease ResearchR01HL113548 · NHLBI · EMORY UNIVERSITY · PI PENG, LIMIN · 2012 to 2021
$3.1M
Research Training in Pediatric Critical Care MedicineT32HD049303 · NICHD · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI JEFFREY R FINEMAN · 2006 to 2026
$3.1M
NHLBI NIH HHS R01 HL113548NICHD NIH HHS T32 HD049303NIDDK NIH HHS P30 DK089507
6 · The paper itself

Abstract

backgroundLower socioeconomic status (SES) and environmental tobacco smoke (ETS) exposure are both associated with poorer disease outcomes in cystic fibrosis (CF), and children with low SES are disproportionately exposed to ETS. We analyzed a large cohort of young children with CF to distinguish the impact of SES and ETS on clinical outcomes.

methodsThe Early Pseudomonas Infection Control Observational study enrolled Pseudomonas-negative young children with CF <13 years of age. An enrollment survey assessed SES and ETS exposures. Forced expiratory volume in 1 second (FEV

resultsOf 1797 participants, 1375 were eligible for analysis. Maternal education was high school or less in 28.1%, 26.8% had household income <$40 000, and 43.8% had Medicaid or no insurance. Maternal smoking after birth was present in 24.8%, more prevalent in household with low SES. In separate models, lower SES and ETS exposure were significantly associated with lower FEV

conclusionsETS exposure was disproportionately high in low SES families in this cohort of children with CF. Lower SES and ETS exposure had independent adverse effects on pulmonary and nutritional outcomes. Estimated effect of SES on FEV

Indexed as

Socioeconomic FactorsBody WeightChildChild, PreschoolCohort StudiesCystic FibrosisFemaleFollow-Up StudiesForced Expiratory VolumeHumansInfantInfant, NewbornLongitudinal StudiesMaleRespiratory SoundsTobacco Smoke PollutionTobacco Smoke Pollution

Identifiers

PMID28093464
PMCPMC5260155
OpenAlexW2571759886

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.